Teva Pharmaceutical Industries Limited Stock News & Updates

Teva Pharmaceuticals: Schizophrenia Treatment Without Monitoring Requirements Gains U.S. Market Access

Teva is increasingly focusing on specialty medications and aims for up to $16.8 billion in revenue...